US Stock MarketDetailed Quotes
SZLSF STAGEZERO LIFE SCIENCES LTD
- 0.024
- -0.044-65.10%
15min DelayClose Jan 10 16:00 ET
2.93MMarket Cap-0.20P/E (TTM)
0.024High0.024Low299Volume0.024Open0.068Pre Close7.09Turnover0.00%Turnover RatioLossP/E (Static)123.53MShares1.00052wk High-0.26P/B2.93MFloat Cap0.00252wk Low--Dividend TTM123.53MShs Float1.000Historical High--Div YieldTTM0.00%Amplitude0.002Historical Low0.023Avg Price1Lot Size
STAGEZERO LIFE SCIENCES LTD Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -78.55%10.26K | -991.86%-62.92K | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 60.59%-3.53M | 77.06%-655.15K | 97.22%-71.07K | 77.21%-558.28K |
| Net income from continuing operations | 51.42%-399.28K | -61.74%-649.46K | 78.68%-386.35K | -1,722.52%-821.88K | 68.67%-401.54K | -206.84%-1.81M | -52.53%-11.42M | -313.78%-9.5M | 97.97%-45.1K | -129.60%-1.28M |
| Operating gains losses | 138.87%73.11K | 43.83%-147.48K | -92.19%29.41K | 80.57%-188.09K | -2,703.17%-262.55K | 128.57%376.37K | 19.03%-2.24M | 109.22%58.44K | 3.64%-967.84K | 99.86%-9.37K |
| Depreciation and amortization | -143.91%-16.73K | -26.46%43.81K | -69.32%18.28K | -77.52%38.1K | -27.41%59.58K | -36.04%59.58K | -14.10%437.45K | -31.46%125.76K | -20.57%169.44K | 54.91%82.08K |
| Other non cash items | -62.40%26.45K | -60.53%69.84K | -82.23%23.58K | 141.53%70.34K | 126.22%176.95K | 118.20%132.7K | -520.52%-1.66M | 71.65%-117.37K | -209.00%-169.37K | -784.84%-674.84K |
| Change In working capital | -53.65%314.81K | 63.11%608.59K | -77.80%210.2K | -27.88%679.17K | -74.98%373.12K | 605.10%946.67K | 905.95%3.71M | 463.44%1.14M | 184.09%941.78K | 2,465.65%1.49M |
| -Change in receivables | 839.42%46.14K | -292.99%-42.56K | 81.40%-7.67K | -130.49%-6.24K | -50.35%22.05K | -309.51%-41.21K | 121.57%95.65K | -83.02%11.11K | 268.89%20.47K | 147.07%44.42K |
| -Change in inventory | -149.03%-29.6K | --0 | --0 | 1,725.61%60.37K | --0 | -80.41%12.68K | 682.05%313.18K | -54.32%142.77K | 101.75%3.31K | 200.61%102.4K |
| -Change in prepaid assets | -153.17%-31.85K | 113.57%16.06K | 86.08%30.65K | -12.13%59.9K | -11.14%-118.34K | -21.09%16.47K | 205.87%26.09K | 7.98%43.53K | -9.60%68.17K | 25.36%-106.48K |
| -Change in payables and accrued expense | -26.82%329.64K | 17.95%686.14K | -81.35%167.58K | -52.49%450.43K | -60.81%581.73K | 8,782.63%898.48K | 960.22%3.4M | 497.47%957.76K | 229.99%948.08K | 256.25%1.48M |
| -Change in other working capital | -99.58%477 | 54.55%-51.06K | -67.41%19.64K | 216.76%114.71K | -234.38%-112.33K | 218.74%60.25K | -326.82%-126.41K | -153.17%-13.47K | -157.83%-98.25K | -70.14%-33.59K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -78.55%10.26K | -991.86%-62.92K | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 60.59%-3.53M | 77.06%-655.15K | 97.22%-71.07K | 77.21%-558.28K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | |||||||
| Net PPE purchase and sale | ---- | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 81.87%-15.95K | 274.50%78.11K | -70.44%72.09K | -177.34%-87.93K | -47.45%20.86K | -78.40%243.85K | -55.34%1.83M | -77.63%650.6K | 215.83%113.7K | -88.68%39.69K |
| Net issuance payments of debt | 86.33%-15.95K | 126.39%78.11K | -70.44%72.09K | -202.62%-116.67K | -845.62%-295.95K | 354.85%243.85K | 174.71%290.18K | 442.17%332.47K | 215.83%113.7K | 150.62%39.69K |
| Net common stock issuance | --0 | --0 | ---- | --18.52K | --279.76K | ---- | -50.36%1.54M | -93.37%206K | --0 | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | ---- | --10.22K | --37.04K | ---- | --0 | --0 | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 81.87%-15.95K | 274.50%78.11K | -70.44%72.09K | -177.34%-87.93K | -47.45%20.86K | -78.40%243.85K | -55.34%1.83M | -77.63%650.6K | 215.83%113.7K | -88.68%39.69K |
| Net cash flow | ||||||||||
| Beginning cash position | -67.73%20.72K | -84.75%5.54K | 68.22%26.38K | 784.94%64.21K | -94.04%36.3K | -99.09%15.68K | -73.86%1.72M | -97.91%33.25K | -100.22%-9.37K | -90.55%609.21K |
| Current changes in cash | 85.82%-5.69K | -45.59%15.19K | -201.15%-20.85K | -194.11%-40.11K | 105.38%27.91K | 101.85%20.61K | 65.19%-1.7M | -103.43%-4.56K | 101.61%42.63K | 76.42%-518.59K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---13.01K | ---- | ---- | ---- |
| End cash Position | -37.61%15.03K | -67.73%20.72K | -84.75%5.54K | -27.55%24.09K | -29.15%64.21K | -94.04%36.3K | -99.09%15.68K | -99.09%15.68K | -97.91%33.25K | -97.86%90.63K |
| Free cash flow | -78.55%10.26K | -991.86%-62.92K | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 61.24%-3.53M | 77.10%-655.15K | 97.22%-71.07K | 78.47%-558.28K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data